ImmuneOncia aims to develop immuno-oncology therapeutics

to transform the standard of care in cancer treatment

  • IR/PR
  • Disclosures

Disclosures

Submission Date Disclosure Title Author
2026-04-02 Ex-Rights (유상증자) 코스닥시장본부
2026-04-02 Prospectus 이뮨온시아
2026-04-02 [Conditions for issuance finalized]Registration Statement (Equity securities) 이뮨온시아
2026-04-02 [Corrected description]Decision on Capital Increase with Consideration 이뮨온시아
2026-04-02 Initial (Tentative) Issue Price of Rights Offering 이뮨온시아
2026-04-02 Effectiveness Information( 2026.3.18. 제출 증권신고서(지분증권) ) 금융감독원
2026-04-01 Report on the Appointment, Dismissal or Early Retirement of Outside Directors 이뮨온시아
2026-03-31 Outcomes of Annual Meeting of Shareholders 이뮨온시아
2026-03-23 Report on trading plan of specific securities, etc. by executive officers and major shareholders 유한양행
2026-03-18 [Corrected description]Registration Statement (Equity securities) 이뮨온시아
1 2 3 4 5